Search

Your search keyword '"Junichi Tomomatsu"' showing total 78 results

Search Constraints

Start Over You searched for: Author "Junichi Tomomatsu" Remove constraint Author: "Junichi Tomomatsu"
78 results on '"Junichi Tomomatsu"'

Search Results

51. Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib.

52. Diagnostic Problems Among Chronic Lymphocytic Leukemia and Other Indolent B-cell Leukemias in a Japanese Population

53. Eight patients with mucosal malignant melanoma treated by nivolumab: a retrospective analysis in a single institution

54. Phase 1 study of ipatasertib (AKT inhibitor) for investigating safety, tolerability, pharmacokinetics (PK), efficacy, and biomarkers in Japanese patients (pts) with solid tumors including castration-resistant prostate cancer (CRPC)

55. The retrospective analysis of nephrotoxicity for cisplatin dose of CRT compared 100mg/m2 to 80mg/m2 for head and neck cancer (HNC) patients

56. Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy

57. Incidence and risk factors of interstitial lung disease (ILD) of head and neck cancer patients treated with Cetuximab

58. A phase 1 study of BYL719, an α-isoform selective PI3K inhibitor, in Japanese patients with advanced solid malignancies

59. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome

61. Weekly Paclitaxel plus Cetuximab in the primary treatment of metastatic/recurrent squamous cell cancer of head and neck

62. A comparison of cetuximab-containing regimens for recurrent/metastatic squamous cell head and neck carcinoma: the clinical significance of weekly paclitaxel and cetuximab

63. Clinical significance of relative dose intensity during pazopanib treatment to advanced/metastatic soft tissue sarcoma (STS) patients

64. Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior

65. Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphoma

66. Abstract C120: Phase I study of the safety and tolerability of LJM716 in Japanese patients with advanced solid tumors

67. Management and treatment of soft tissue sarcoma patients by medical oncologists in multidisciplinary center

68. Non-myeloablative allogenic BMT for myelodysplastic syndrome successfully controlled accompanying relapsing polychondritis

69. Risk Factors of Prolonged Duration of Gastrosoma Placement in Locally Advanced Head and Neck Cancer Patients with Ccrt

70. Opioid Requirements to Control Mucositis During Chemoradiotherapy in Head and Neck Cancer: Cisplatin Vs. Cetuximab

71. Incidence of Pneumothorax in Advanced and/or Metastatic Soft Tissue Sarcoma Patients during Pazopanib Treatment

73. Multiple brain infarctions induced by imatinib mesylate in a patient with clonal eosinophilia

74. Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis.

75. Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.

77. Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis

78. Risk factors of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment

Catalog

Books, media, physical & digital resources